Short- and long-term treatment with estradiol or progesterone modifies the expression of GFAP, MAP2 and Tau in prefrontal cortex and hippocampus

Life Sci. 2011 Jul 18;89(3-4):123-8. doi: 10.1016/j.lfs.2011.05.008. Epub 2011 Jun 12.

Abstract

Aims: We analyzed the effects of the short- and long-term administration of estradiol (E2) or progesterone (P4) after ovariectomy on the expression of MAP2, Tau and GFAP in prefrontal cortex and hippocampus.

Main methods: Sprague Dawley rats were ovariectomized and immediately treated with E2 or P4 for 2 or 18 weeks. At the end of treatments, hippocampus and prefrontal cortex were excised, proteins were extracted and MAP2, Tau and GFAP were analyzed by Western blot.

Key findings: MAP2 and Tau content was not modified by E2 in the prefrontal cortex. On the contrary, P4 decreased MAP2 content after a short-term treatment, while it increased that of MAP2 and TAU in this brain region after a long-term treatment. E2 increased MAP2 content in hippocampus. In this region, short-term administration of P4 increased that of MAP2. GFAP content was diminished after a long-term administration of P4 in hippocampus.

Significance: Current data emphasize the importance of short- and long-term sex steroid treatment on neuronal and glial cytoskeletal proteins expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Estradiol / pharmacology*
  • Female
  • Glial Fibrillary Acidic Protein / metabolism*
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Microtubule-Associated Proteins / metabolism*
  • Ovariectomy
  • Prefrontal Cortex / drug effects*
  • Prefrontal Cortex / metabolism
  • Progesterone / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • tau Proteins / metabolism*

Substances

  • Glial Fibrillary Acidic Protein
  • MAP2 protein, rat
  • Mapt protein, rat
  • Microtubule-Associated Proteins
  • tau Proteins
  • Progesterone
  • Estradiol